+1 347 708 0418
The Thalassemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Thalassemia size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Thalassemia market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Thalassemia market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Iron Chelating Drugs
Others
Market segment by Application, can be divided into
Hospital
Clinic
Research Institute
Laboratories
Others
Market segment by players, this report covers
Bluebird bio, Inc.
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
IONIS Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Thalassemia product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Thalassemia, with revenue, gross margin and global market share of Thalassemia from 2019 to 2021.
Chapter 3, the Thalassemia competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Thalassemia market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Thalassemia research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Thalassemia
1.2 Classification of Thalassemia by Type
1.2.1 Overview: Global Thalassemia Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Thalassemia Revenue Market Share by Type in 2020
1.2.3 Iron Chelating Drugs
1.2.4 Others
1.3 Global Thalassemia Market by Application
1.3.1 Overview: Global Thalassemia Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Laboratories
1.3.6 Others
1.4 Global Thalassemia Market Size & Forecast
1.5 Global Thalassemia Market Size and Forecast by Region
1.5.1 Global Thalassemia Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Thalassemia Market Size by Region, (2016-2021)
1.5.3 North America Thalassemia Market Size and Prospect (2016-2026)
1.5.4 Europe Thalassemia Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Thalassemia Market Size and Prospect (2016-2026)
1.5.6 South America Thalassemia Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Thalassemia Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Thalassemia Market Drivers
1.6.2 Thalassemia Market Restraints
1.6.3 Thalassemia Trends Analysis
2 Company Profiles
2.1 Bluebird bio, Inc.
2.1.1 Bluebird bio, Inc. Details
2.1.2 Bluebird bio, Inc. Major Business
2.1.3 Bluebird bio, Inc. Thalassemia Product and Solutions
2.1.4 Bluebird bio, Inc. Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bluebird bio, Inc. Recent Developments and Future Plans
2.2 Acceleron Pharma, Inc.
2.2.1 Acceleron Pharma, Inc. Details
2.2.2 Acceleron Pharma, Inc. Major Business
2.2.3 Acceleron Pharma, Inc. Thalassemia Product and Solutions
2.2.4 Acceleron Pharma, Inc. Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Acceleron Pharma, Inc. Recent Developments and Future Plans
2.3 Celgene Corporation
2.3.1 Celgene Corporation Details
2.3.2 Celgene Corporation Major Business
2.3.3 Celgene Corporation Thalassemia Product and Solutions
2.3.4 Celgene Corporation Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Celgene Corporation Recent Developments and Future Plans
2.4 GlaxoSmithKline plc
2.4.1 GlaxoSmithKline plc Details
2.4.2 GlaxoSmithKline plc Major Business
2.4.3 GlaxoSmithKline plc Thalassemia Product and Solutions
2.4.4 GlaxoSmithKline plc Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline plc Recent Developments and Future Plans
2.5 Incyte Corporation
2.5.1 Incyte Corporation Details
2.5.2 Incyte Corporation Major Business
2.5.3 Incyte Corporation Thalassemia Product and Solutions
2.5.4 Incyte Corporation Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Incyte Corporation Recent Developments and Future Plans
2.6 Gamida Cell
2.6.1 Gamida Cell Details
2.6.2 Gamida Cell Major Business
2.6.3 Gamida Cell Thalassemia Product and Solutions
2.6.4 Gamida Cell Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Gamida Cell Recent Developments and Future Plans
2.7 Kiadis Pharma
2.7.1 Kiadis Pharma Details
2.7.2 Kiadis Pharma Major Business
2.7.3 Kiadis Pharma Thalassemia Product and Solutions
2.7.4 Kiadis Pharma Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Kiadis Pharma Recent Developments and Future Plans
2.8 La Jolla Pharmaceutical Company
2.8.1 La Jolla Pharmaceutical Company Details
2.8.2 La Jolla Pharmaceutical Company Major Business
2.8.3 La Jolla Pharmaceutical Company Thalassemia Product and Solutions
2.8.4 La Jolla Pharmaceutical Company Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 La Jolla Pharmaceutical Company Recent Developments and Future Plans
2.9 IONIS Pharmaceuticals
2.9.1 IONIS Pharmaceuticals Details
2.9.2 IONIS Pharmaceuticals Major Business
2.9.3 IONIS Pharmaceuticals Thalassemia Product and Solutions
2.9.4 IONIS Pharmaceuticals Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 IONIS Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Thalassemia Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Thalassemia Players Market Share
3.2.2 Top 10 Thalassemia Players Market Share
3.2.3 Market Competition Trend
3.3 Thalassemia Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Thalassemia Revenue and Market Share by Type (2016-2021)
4.2 Global Thalassemia Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Thalassemia Revenue Market Share by Application (2016-2021)
5.2 Thalassemia Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Thalassemia Revenue by Type (2016-2026)
6.2 North America Thalassemia Revenue by Application (2016-2026)
6.3 North America Thalassemia Market Size by Country
6.3.1 North America Thalassemia Revenue by Country (2016-2026)
6.3.2 United States Thalassemia Market Size and Forecast (2016-2026)
6.3.3 Canada Thalassemia Market Size and Forecast (2016-2026)
6.3.4 Mexico Thalassemia Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Thalassemia Revenue by Type (2016-2026)
7.2 Europe Thalassemia Revenue by Application (2016-2026)
7.3 Europe Thalassemia Market Size by Country
7.3.1 Europe Thalassemia Revenue by Country (2016-2026)
7.3.2 Germany Thalassemia Market Size and Forecast (2016-2026)
7.3.3 France Thalassemia Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Thalassemia Market Size and Forecast (2016-2026)
7.3.5 Russia Thalassemia Market Size and Forecast (2016-2026)
7.3.6 Italy Thalassemia Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Thalassemia Revenue by Type (2016-2026)
8.2 Asia-Pacific Thalassemia Revenue by Application (2016-2026)
8.3 Asia-Pacific Thalassemia Market Size by Region
8.3.1 Asia-Pacific Thalassemia Revenue by Region (2016-2026)
8.3.2 China Thalassemia Market Size and Forecast (2016-2026)
8.3.3 Japan Thalassemia Market Size and Forecast (2016-2026)
8.3.4 South Korea Thalassemia Market Size and Forecast (2016-2026)
8.3.5 India Thalassemia Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Thalassemia Market Size and Forecast (2016-2026)
8.3.7 Australia Thalassemia Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Thalassemia Revenue by Type (2016-2026)
9.2 South America Thalassemia Revenue by Application (2016-2026)
9.3 South America Thalassemia Market Size by Country
9.3.1 South America Thalassemia Revenue by Country (2016-2026)
9.3.2 Brazil Thalassemia Market Size and Forecast (2016-2026)
9.3.3 Argentina Thalassemia Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Thalassemia Revenue by Type (2016-2026)
10.2 Middle East & Africa Thalassemia Revenue by Application (2016-2026)
10.3 Middle East & Africa Thalassemia Market Size by Country
10.3.1 Middle East & Africa Thalassemia Revenue by Country (2016-2026)
10.3.2 Turkey Thalassemia Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Thalassemia Market Size and Forecast (2016-2026)
10.3.4 UAE Thalassemia Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Thalassemia Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Thalassemia Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Thalassemia Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Thalassemia Revenue (USD Million) by Region (2016-2021)
Table 5. Global Thalassemia Revenue Market Share by Region (2021-2026)
Table 6. Bluebird bio, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Bluebird bio, Inc. Major Business
Table 8. Bluebird bio, Inc. Thalassemia Product and Solutions
Table 9. Bluebird bio, Inc. Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Acceleron Pharma, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Acceleron Pharma, Inc. Major Business
Table 12. Acceleron Pharma, Inc. Thalassemia Product and Solutions
Table 13. Acceleron Pharma, Inc. Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 15. Celgene Corporation Major Business
Table 16. Celgene Corporation Thalassemia Product and Solutions
Table 17. Celgene Corporation Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors
Table 19. GlaxoSmithKline plc Major Business
Table 20. GlaxoSmithKline plc Thalassemia Product and Solutions
Table 21. GlaxoSmithKline plc Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Incyte Corporation Corporate Information, Head Office, and Major Competitors
Table 23. Incyte Corporation Major Business
Table 24. Incyte Corporation Thalassemia Product and Solutions
Table 25. Incyte Corporation Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Gamida Cell Corporate Information, Head Office, and Major Competitors
Table 27. Gamida Cell Major Business
Table 28. Gamida Cell Thalassemia Product and Solutions
Table 29. Gamida Cell Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Kiadis Pharma Corporate Information, Head Office, and Major Competitors
Table 31. Kiadis Pharma Major Business
Table 32. Kiadis Pharma Thalassemia Product and Solutions
Table 33. Kiadis Pharma Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. La Jolla Pharmaceutical Company Corporate Information, Head Office, and Major Competitors
Table 35. La Jolla Pharmaceutical Company Major Business
Table 36. La Jolla Pharmaceutical Company Thalassemia Product and Solutions
Table 37. La Jolla Pharmaceutical Company Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. IONIS Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. IONIS Pharmaceuticals Major Business
Table 40. IONIS Pharmaceuticals Thalassemia Product and Solutions
Table 41. IONIS Pharmaceuticals Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Thalassemia Revenue (USD Million) by Players (2019-2021)
Table 43. Global Thalassemia Revenue Share by Players (2019-2021)
Table 44. Breakdown of Thalassemia by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Thalassemia Players Head Office, Products and Services Provided
Table 46. Thalassemia Mergers & Acquisitions in the Past Five Years
Table 47. Thalassemia New Entrants and Expansion Plans
Table 48. Global Thalassemia Revenue (USD Million) by Type (2016-2021)
Table 49. Global Thalassemia Revenue Share by Type (2016-2021)
Table 50. Global Thalassemia Revenue Forecast by Type (2021-2026)
Table 51. Global Thalassemia Revenue by Application (2016-2021)
Table 52. Global Thalassemia Revenue Forecast by Application (2021-2026)
Table 53. North America Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Thalassemia Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Thalassemia Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Thalassemia Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Thalassemia Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Thalassemia Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Thalassemia Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Thalassemia Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Thalassemia Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Thalassemia Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Thalassemia Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Thalassemia Picture
Figure 2. Global Thalassemia Revenue Market Share by Type in 2020
Figure 3. Iron Chelating Drugs
Figure 4. Others
Figure 5. Thalassemia Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Research Institute Picture
Figure 9. Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Thalassemia Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Thalassemia Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Thalassemia Revenue Market Share by Region (2016-2026)
Figure 14. Global Thalassemia Revenue Market Share by Region in 2020
Figure 15. North America Thalassemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Thalassemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Thalassemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Thalassemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Thalassemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Thalassemia Market Drivers
Figure 21. Thalassemia Market Restraints
Figure 22. Thalassemia Market Trends
Figure 23. Bluebird bio, Inc. Recent Developments and Future Plans
Figure 24. Acceleron Pharma, Inc. Recent Developments and Future Plans
Figure 25. Celgene Corporation Recent Developments and Future Plans
Figure 26. GlaxoSmithKline plc Recent Developments and Future Plans
Figure 27. Incyte Corporation Recent Developments and Future Plans
Figure 28. Gamida Cell Recent Developments and Future Plans
Figure 29. Kiadis Pharma Recent Developments and Future Plans
Figure 30. La Jolla Pharmaceutical Company Recent Developments and Future Plans
Figure 31. IONIS Pharmaceuticals Recent Developments and Future Plans
Figure 32. Global Thalassemia Revenue Share by Players in 2020
Figure 33. Thalassemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Thalassemia Revenue Market Share in 2020
Figure 35. Global Top 10 Players Thalassemia Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Thalassemia Revenue Share by Type in 2020
Figure 38. Global Thalassemia Market Share Forecast by Type (2021-2026)
Figure 39. Global Thalassemia Revenue Share by Application in 2020
Figure 40. Global Thalassemia Market Share Forecast by Application (2021-2026)
Figure 41. North America Thalassemia Sales Market Share by Type (2016-2026)
Figure 42. North America Thalassemia Sales Market Share by Application (2016-2026)
Figure 43. North America Thalassemia Revenue Market Share by Country (2016-2026)
Figure 44. United States Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Thalassemia Sales Market Share by Type (2016-2026)
Figure 48. Europe Thalassemia Sales Market Share by Application (2016-2026)
Figure 49. Europe Thalassemia Revenue Market Share by Country (2016-2026)
Figure 50. Germany Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Thalassemia Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Thalassemia Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Thalassemia Revenue Market Share by Region (2016-2026)
Figure 58. China Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Thalassemia Sales Market Share by Type (2016-2026)
Figure 65. South America Thalassemia Sales Market Share by Application (2016-2026)
Figure 66. South America Thalassemia Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Thalassemia Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Thalassemia Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Thalassemia Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Buy
